A comparative review of conventional and lipid formulations of amphotericin B. (Q33727839)

From Wikidata

Revision as of 23:07, 18 March 2019 by Renamerr (talk | contribs) (‎Changed Ukrainian description: наукова стаття, опублікована в серпні 1999, #quickstatements; batch #9431 by User:Renamerr)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A comparative review of conventional and lipid formulations of amphotericin B.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

A comparative review of conventional and lipid formulations of amphotericin B. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Robinson RF

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Nahata MC

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Journal of Clinical Pharmacy and Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

249-257

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Clinical use of amphotericin B and derivatives: lore, mystique, and fact

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00220.X

21 January 2018

Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00220.X

21 January 2018

Lipid formulations of amphotericin B: clinical efficacy and toxicities

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00220.X

21 January 2018

Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00220.X

21 January 2018

Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00220.X

21 January 2018

Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00220.X

21 January 2018

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00220.X

21 January 2018

Amphotericin B Use in a Community Hospital, with Special Emphasis on Side Effects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00220.X

21 January 2018

Identifiers

10.1046/J.1365-2710.1999.00220.X

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33727839&oldid=887285947"